293 related articles for article (PubMed ID: 24556277)
1. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
[TBL] [Abstract][Full Text] [Related]
3. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.
Yang JB; Wang YH; Yang W; Lu FT; Ma HD; Zhao ZB; Jia YJ; Tang W; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
J Autoimmun; 2016 Jan; 66():108-17. PubMed ID: 26432598
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis reveals distinctive protein profiles involved in CD8
Zhang W; Zhang R; Zhang J; Sun Y; Leung PS; Yang GX; Shuai Z; Ridgway WM; Gershwin ME
Cell Mol Immunol; 2018 Aug; 15(8):756-767. PubMed ID: 29375127
[TBL] [Abstract][Full Text] [Related]
6. Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis.
Itoh A; Adams D; Huang W; Wu Y; Kachapati K; Bednar KJ; Leung PSC; Zhang W; Flavell RA; Gershwin ME; Ridgway WM
Hepatology; 2021 Aug; 74(2):835-846. PubMed ID: 33462854
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8
Ma HD; Ma WT; Liu QZ; Zhao ZB; Liu MZ; Tsuneyama K; Gao JM; Ridgway WM; Ansari AA; Gershwin ME; Fei YY; Lian ZX
J Autoimmun; 2017 Mar; 78():19-28. PubMed ID: 28129932
[TBL] [Abstract][Full Text] [Related]
8. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.
Wang YH; Yang W; Yang JB; Jia YJ; Tang W; Gershwin ME; Ridgway WM; Lian ZX
J Autoimmun; 2015 May; 59():26-37. PubMed ID: 25701076
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous development of an autoimmune hepatitis - primary biliary cholangitis overlap syndrome in dnTGFβRII Aire
Long J; Yang SY; Huang MX; Luo PY; Li L; Tsuneyama K; Ansari AA; Lu L; Gershwin ME; Lian ZX; Zhao ZB
J Pathol; 2023 Jun; 260(2):222-234. PubMed ID: 36853094
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Characterization of Hepatic CD8
Han Y; Bian ZH; Yang SY; Wang CB; Li L; Yang YQ; Ansari AA; Gershwin ME; Zeng X; Lian ZX; Zhao ZB
Front Immunol; 2022; 13():860311. PubMed ID: 35514982
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells in inflamed liver are dysfunctional in murine primary biliary cholangitis.
Lin CI; Wang YW; Liu CY; Chen HW; Liang PH; Chuang YH
Clin Exp Immunol; 2024 Feb; 215(3):225-239. PubMed ID: 37916967
[TBL] [Abstract][Full Text] [Related]
14. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
[TBL] [Abstract][Full Text] [Related]
15. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
[TBL] [Abstract][Full Text] [Related]
16. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
[TBL] [Abstract][Full Text] [Related]
17. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
[TBL] [Abstract][Full Text] [Related]
18. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
[TBL] [Abstract][Full Text] [Related]
19. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.
Stein S; Henze L; Poch T; Carambia A; Krech T; Preti M; Schuran FA; Reich M; Keitel V; Fiorotto R; Strazzabosco M; Fischer L; Li J; Müller LM; Wagner J; Gagliani N; Herkel J; Schwinge D; Schramm C
J Hepatol; 2021 Apr; 74(4):919-930. PubMed ID: 33197512
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
